SCHEMBL6474891

SCHEMBL6474891

Cn1cc(O)nc1N.[Cu]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6280996 0.98 BACE1 (0.32)
Methyl Alcohol SCHEMBL28491792 0.95 BACE1 (0.31)
Hydrogen Peroxide SCHEMBL3487883 0.95 BACE1 (0.31)
SCHEMBL27857127 0.95
SCHEMBL8637088 0.95
Ammonia Solution, Strong SCHEMBL28815279 0.95
Hydrochloric Acid SCHEMBL1241282 0.95
SCHEMBL22157240 0.95
Bromide SCHEMBL21404082 0.95
Phosphine SCHEMBL28250968 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102128919-B Composition and use thereof ACON BIOTECH HANGZHOU CO LTD 2013-12-04 CN claimed
CN-102128919-A Composition and use thereof ACON BIOTECH HANGZHOU CO LTD 2011-07-20 CN claimed
US-6844200-B2 Device for carrying out lateral-flow assays involving more than one analyte BAYER CORPORATION (US) 2005-01-18 US disclosed
EP-0978568-B1 Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity BAYER AG (US) 2004-09-29 EP disclosed
WO-2004060832-A2 FLUORESCENT CREATININE ASSAY BAYER HEALTHCARE LLC (US) 2004-07-22 WO disclosed
US-20020001818-A1 Device for carrying out lateral-flow assays involving more than one analyte BAYER CORPORATION 2002-01-03 US disclosed
US-6297020-B1 APPARATUS FOR THE DETERMINATION OF CONCENTRATION OF PREFERENTIAL PARTICLES IN SAMPLE BAYER CORPORATION 2001-10-02 US disclosed
EP-1033575-A2 Device for carrying out lateral-flow assays involving more than one analyte Bayer Corporation (US) 2000-09-06 EP disclosed